0 Комментарии
0 Поделились
352 Просмотры
0 предпросмотр
Спонсоры
Поиск
Знакомьтесь и заводите новых друзей
-
Войдите, чтобы отмечать, делиться и комментировать!
-
Are Statins Still the First Choice for Managing Cardiovascular Risk Worldwide?According to the latest report published by Data Bridge Market Research, the Statin Market CAGR Value The global statin market was valued at USD 16.85 billion in 2024 and is expected to reach USD 24.34 billion by 2032During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 4.70%, primarily driven by the rising prevalence of cardiovascular The...0 Комментарии 0 Поделились 69 Просмотры 0 предпросмотр
-
Dobutamine Market Growing at 5.8% CAGR Through 2034According to a new report from Intel Market Research, the global Dobutamine market was valued at USD 1.05 billion in 2025 and is projected to grow from USD 1.12 billion in 2026 to USD 1.75 billion by 2034, exhibiting a robust CAGR of 5.8% during the forecast period (2026–2034). This growth is propelled by the rising global prevalence of cardiovascular diseases, the expanding aging...0 Комментарии 0 Поделились 388 Просмотры 0 предпросмотр
-
Key Insights into the U.S. Statin Market Growth and DemandExecutive Summary U.S. Statin Market Size and Share: Global Industry Snapshot CAGR Value The U.S. statin market size was valued at USD 4.59 billion in 2024 and is expected to reach USD 1.57 billion by 2032, at a CAGR of 1.50% during the forecast period Each of the topics covered in the U.S. Statin report is studied very well to get a clear idea about all the factors that are...0 Комментарии 0 Поделились 428 Просмотры 0 предпросмотр
Спонсоры
Спонсоры